PL3766522T3 - Zautomatyzowany sposób wytwarzania kompozycji 18f-flucyklowiny - Google Patents

Zautomatyzowany sposób wytwarzania kompozycji 18f-flucyklowiny

Info

Publication number
PL3766522T3
PL3766522T3 PL20196030T PL20196030T PL3766522T3 PL 3766522 T3 PL3766522 T3 PL 3766522T3 PL 20196030 T PL20196030 T PL 20196030T PL 20196030 T PL20196030 T PL 20196030T PL 3766522 T3 PL3766522 T3 PL 3766522T3
Authority
PL
Poland
Prior art keywords
fluciclovine
compositions
preparation
automated method
automated
Prior art date
Application number
PL20196030T
Other languages
English (en)
Inventor
Kristine ROMOREN
Olav Ryan
Original Assignee
Ge Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Limited filed Critical Ge Healthcare Limited
Priority claimed from EP12806500.0A external-priority patent/EP2793954B1/en
Publication of PL3766522T3 publication Critical patent/PL3766522T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0404Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B9/00General methods of preparing halides
    • C01B9/08Fluorides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL20196030T 2010-12-29 2012-12-21 Zautomatyzowany sposób wytwarzania kompozycji 18f-flucyklowiny PL3766522T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201061427839P 2010-12-29 2010-12-29
PCT/EP2011/073670 WO2012089594A1 (en) 2010-12-29 2011-12-21 Eluent solution
EP20196030.9A EP3766522B1 (en) 2010-12-29 2012-12-21 Automated method for the preparation of 18f-fluciclovine compositions
EP12806500.0A EP2793954B1 (en) 2011-12-21 2012-12-21 18f-fluciclovine compositions in citrate buffers
PCT/EP2012/076689 WO2013093025A1 (en) 2011-12-21 2012-12-21 18f - fluciclovine compositions in citrate buffers

Publications (1)

Publication Number Publication Date
PL3766522T3 true PL3766522T3 (pl) 2022-07-04

Family

ID=45495902

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11808853T PL2658831T3 (pl) 2010-12-29 2011-12-21 Roztwór eluentu
PL20196030T PL3766522T3 (pl) 2010-12-29 2012-12-21 Zautomatyzowany sposób wytwarzania kompozycji 18f-flucyklowiny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL11808853T PL2658831T3 (pl) 2010-12-29 2011-12-21 Roztwór eluentu

Country Status (16)

Country Link
US (3) US11504430B2 (pl)
EP (2) EP2658831B1 (pl)
JP (1) JP6018581B2 (pl)
KR (3) KR102218263B1 (pl)
CN (2) CN103270004A (pl)
AU (1) AU2011351550B2 (pl)
BR (2) BR112013015396B1 (pl)
CA (1) CA2823063C (pl)
DK (3) DK2658831T3 (pl)
ES (2) ES2621950T3 (pl)
MX (1) MX363538B (pl)
PL (2) PL2658831T3 (pl)
PT (2) PT3766522T (pl)
RU (1) RU2608932C2 (pl)
SG (1) SG10201805198TA (pl)
WO (1) WO2012089594A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013015396B1 (pt) * 2010-12-29 2021-11-03 Ge Healthcare Limited Método para a preparação de 18f para uso em uma reação de radiofluoração, reação de radiofluoração e cassete para a realização da reação de radiofluoração
JP2015501305A (ja) * 2011-10-19 2015-01-15 ピラマル イメージング ソシエテ アノニム F‐18標識Aβリガンドの改良された製造方法
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
PL2793954T3 (pl) * 2011-12-21 2021-04-06 Ge Healthcare Limited KOMPOZYCJE 18F-FLUCYKLOWINY W BUFORACH CYTRYNlANOWYCH
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
CN104762666A (zh) 2013-11-13 2015-07-08 通用电气健康护理有限公司 双重运行盒
US9988336B2 (en) * 2014-03-18 2018-06-05 Mayo Foundation For Medical Education And Research Gaseous F-18 technologies
NL2014828B1 (en) * 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.
JP6827709B2 (ja) * 2016-04-25 2021-02-10 日本メジフィジックス株式会社 2−[18f]フルオロ−2−デオキシ−d−グルコースの製造方法
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
JP7148121B2 (ja) * 2018-08-31 2022-10-05 国立大学法人北海道大学 放射性核種18fの精製方法
GB202005282D0 (en) * 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations
JP7127164B2 (ja) * 2021-01-19 2022-08-29 日本メジフィジックス株式会社 2-[18f]フルオロ-2-デオキシ-d-グルコースの製造方法
CN113372399A (zh) * 2021-06-04 2021-09-10 江苏华益科技有限公司 一种氟[18f]脱氧葡糖注射液的合成方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425063A (en) * 1993-04-05 1995-06-13 Associated Universities, Inc. Method for selective recovery of PET-usable quantities of [18 F] fluoride and [13 N] nitrate/nitrite from a single irradiation of low-enriched [18 O] water
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
EP1356827A1 (en) 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
JP2006505610A (ja) 2002-11-05 2006-02-16 イヨン ベアム アプリカスィヨン エッス.アー. 18−f標識放射性製剤の安定化
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
GB0425501D0 (en) * 2004-11-19 2004-12-22 Amersham Plc Fluoridation process
US7235216B2 (en) * 2005-05-01 2007-06-26 Iba Molecular North America, Inc. Apparatus and method for producing radiopharmaceuticals
GB0524851D0 (en) * 2005-12-06 2006-01-11 Ge Healthcare Ltd Radiolabelling method using polymers
KR101554366B1 (ko) 2006-06-21 2015-09-18 지이 헬쓰케어 리미티드 방사성 의약품
WO2008056481A1 (fr) 2006-11-09 2008-05-15 Nihon Medi-Physics Co., Ltd. Agent d'imagerie de diagnostic radioactif
PL2106808T3 (pl) 2006-12-21 2018-07-31 Nihon Medi-Physics Co., Ltd. Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy
TWI406674B (zh) * 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
EP2017359A3 (en) * 2007-06-11 2009-08-05 Trasis S.A. Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step
KR101009712B1 (ko) 2007-02-22 2011-01-19 재단법인 아산사회복지재단 양성자성 용매와 이에 녹는 염들을 이용한 음이온 교환고분자 지지체로부터의 플루오린-18 플루오라이드 용리와이를 이용한 플루오린-18의 표지방법
WO2008106442A1 (en) * 2007-02-27 2008-09-04 Ge Healthcare Limited Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate
EP1990310A1 (en) 2007-04-23 2008-11-12 Trasis S.A. Method for the preparation of reactive 18F fluoride, and for the labeling of radiotracers, using a modified non-ionic solid support and without any evaporation step
WO2009045535A2 (en) * 2007-10-04 2009-04-09 Sloan-Kettering Institute For Cancer Research Fluorine-18 derivative of dasatinib and uses thereof
CN101939290B (zh) 2007-12-19 2013-11-06 日本医事物理股份有限公司 放射性氟标记的有机化合物的制备方法
US20090171272A1 (en) 2007-12-29 2009-07-02 Tegg Troy T Deflectable sheath and catheter assembly
RU2475448C2 (ru) * 2008-01-03 2013-02-20 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ обработки фторида
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
GB0819293D0 (en) * 2008-10-21 2008-11-26 Hammersmith Imanet Ltd Radiofluorination
US20110250137A1 (en) * 2008-12-04 2011-10-13 Bayer Schering Pharma Aktiengesellchaft Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
TW201033713A (en) 2009-03-03 2010-09-16 Wintek Corp Reflective color-changing liquid crystal display
SI2579902T2 (sl) * 2010-06-04 2019-10-30 Life Molecular Imaging Sa Postopek za izdelavo amiloidnih beta ligandov, označenih s F-18
BR112013015396B1 (pt) * 2010-12-29 2021-11-03 Ge Healthcare Limited Método para a preparação de 18f para uso em uma reação de radiofluoração, reação de radiofluoração e cassete para a realização da reação de radiofluoração
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis

Also Published As

Publication number Publication date
CA2823063A1 (en) 2012-07-05
CA2823063C (en) 2020-08-11
KR102218263B1 (ko) 2021-02-22
SG10201805198TA (en) 2018-07-30
US20230068052A1 (en) 2023-03-02
ES2917875T3 (es) 2022-07-12
KR20190119673A (ko) 2019-10-22
KR20190008994A (ko) 2019-01-25
BR112013015396B1 (pt) 2021-11-03
MX363538B (es) 2019-03-27
AU2011351550A1 (en) 2013-07-25
PT3766522T (pt) 2022-06-14
KR102137348B1 (ko) 2020-07-23
BR112014015042A2 (pt) 2017-06-13
KR20130132892A (ko) 2013-12-05
MX2013007699A (es) 2013-08-15
EP2658831B1 (en) 2017-02-15
CN108218650A (zh) 2018-06-29
BR112014015042A8 (pt) 2017-07-04
EP2658831A1 (en) 2013-11-06
PT2793954T (pt) 2021-01-06
WO2012089594A1 (en) 2012-07-05
BR112014015042B1 (pt) 2021-10-26
DK3766522T3 (da) 2022-06-13
US20190192660A1 (en) 2019-06-27
RU2608932C2 (ru) 2017-01-26
PL2658831T3 (pl) 2017-07-31
US11504430B2 (en) 2022-11-22
BR112013015396A2 (pt) 2016-09-20
DK2658831T3 (en) 2017-04-24
DK2793954T3 (da) 2021-01-04
CN103270004A (zh) 2013-08-28
EP3766522B1 (en) 2022-03-23
JP6018581B2 (ja) 2016-11-02
EP3766522A1 (en) 2021-01-20
RU2013126979A (ru) 2015-03-20
AU2011351550B2 (en) 2017-02-02
US20130324715A1 (en) 2013-12-05
JP2014508731A (ja) 2014-04-10
ES2621950T3 (es) 2017-07-05

Similar Documents

Publication Publication Date Title
PT3766522T (pt) Método automático para a preparação de composições de 18f-fluciclovina
ZA201305972B (en) Method for the preparation of biphephos
EP2552873A4 (en) PREPARATION FOR HEXAFLUOR-2-BUTEN
EP2649088A4 (en) COMPOSITIONS FOR SEPARATION METHODS
ZA201306316B (en) Methods and compositions for preparing noribogaine from voacangine
EP3494922C0 (de) Verfahren zur herstellung von teil- oder totalprothesen
EP2691397A4 (en) METHODS AND COMPOSITIONS FOR THE PREPARATION OF NORIBOGAIN FROM VOACANGINE
GB201006753D0 (en) Process for preparing an immunolobulin composition
EP2529006A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN PRODUCTION
IL225510A0 (en) Processes for preparing improved preparations
EP2581089A4 (en) METHOD OF PREPARING POLYPHENOLIC COMPOSITION
HK1183864A1 (zh) 生產喹啉- -羧酰胺的方法
ZA201207972B (en) Methods for enhancing the palatability of comestible compositions
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2593423E (pt) Processo para a preparação de agentes de contraste
EP2571836A4 (en) PROCESS FOR PRODUCING HEXAFLUORO-2-BUTYNE
ZA201303874B (en) Processes for the preparation of enamines
ZA201303870B (en) Processes for the preparation of enamines
PT2390246T (pt) Processo para a preparação de aminaftona
PL391551A1 (pl) Sposób otrzymywania bakteriofagów
ZA201308990B (en) Methods for increasing the palatability of food compositions
ZA201303871B (en) Processes for the preparation of enamines
PL2598504T3 (pl) Sposób otrzymywania dimiracetamu
HK1174328A1 (zh) 用於從伏康京碱製備降伊波加因的方法和組合物